Globus Medical (GMED) News Today

$64.40
+0.45 (+0.70%)
(As of 05/17/2024 ET)
Teacher Retirement System of Texas Cuts Position in Globus Medical, Inc. (NYSE:GMED)
Teacher Retirement System of Texas reduced its holdings in shares of Globus Medical, Inc. (NYSE:GMED - Free Report) by 37.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 28,662 shares of the medical device compan
Globus Medical, Inc. (NYSE:GMED) is Paradice Investment Management LLC's 5th Largest Position
Paradice Investment Management LLC lowered its position in shares of Globus Medical, Inc. (NYSE:GMED - Free Report) by 31.3% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 761,836 shares of the medical device company's stock
Globus Medical, Inc. (NYSE:GMED) Shares Bought by Charles Schwab Investment Management Inc.
Charles Schwab Investment Management Inc. grew its position in Globus Medical, Inc. (NYSE:GMED - Free Report) by 6.3% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,007,812 shares of the medical device company's stock after purchasing an addit
Jump Financial LLC Cuts Stock Position in Globus Medical, Inc. (NYSE:GMED)
Jump Financial LLC decreased its stake in shares of Globus Medical, Inc. (NYSE:GMED - Free Report) by 63.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 25,090 shares of the medical device company's stock after selli
Globus Medical, Inc. (NYSE:GMED) Director Dan Lemaitre Sells 63,300 Shares of Stock
Globus Medical, Inc. (NYSE:GMED - Get Free Report) Director Dan Lemaitre sold 63,300 shares of Globus Medical stock in a transaction that occurred on Friday, May 10th. The stock was sold at an average price of $64.61, for a total transaction of $4,089,813.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.
Globus Medical, Inc. (NYSE:GMED) Short Interest Update
Globus Medical, Inc. (NYSE:GMED - Get Free Report) was the recipient of a large increase in short interest in April. As of April 30th, there was short interest totalling 8,990,000 shares, an increase of 19.7% from the April 15th total of 7,510,000 shares. Based on an average daily volume of 1,120,000 shares, the days-to-cover ratio is presently 8.0 days.
International Assets Investment Management LLC Invests $2.12 Million in Globus Medical, Inc. (NYSE:GMED)
International Assets Investment Management LLC purchased a new stake in shares of Globus Medical, Inc. (NYSE:GMED - Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 39,754 shares of the m
Truist Financial Keeps Their Hold Rating on Globus Medical (GMED)
Essex Investment Management Co. LLC Sells 60,502 Shares of Globus Medical, Inc. (NYSE:GMED)
Essex Investment Management Co. LLC reduced its position in Globus Medical, Inc. (NYSE:GMED - Free Report) by 40.7% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 88,204 shares of the medical devi
Mesirow Institutional Investment Management Inc. Has $15.36 Million Stock Position in Globus Medical, Inc. (NYSE:GMED)
Mesirow Institutional Investment Management Inc. boosted its holdings in shares of Globus Medical, Inc. (NYSE:GMED - Free Report) by 364.1% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 288,238 shares of the medical dev
Globus Medical (NYSE:GMED) Price Target Raised to $70.00
Roth Capital Research Analysts Lower Earnings Estimates for Globus Medical, Inc. (NYSE:GMED)
Globus Medical, Inc. (NYSE:GMED - Free Report) - Investment analysts at Roth Capital reduced their FY2025 earnings estimates for Globus Medical in a research report issued to clients and investors on Wednesday, May 8th. Roth Capital analyst J. Wittes now forecasts that the medical device company
Globus Medical (NYSE:GMED) PT Raised to $85.00
Barclays lifted their price objective on shares of Globus Medical from $83.00 to $85.00 and gave the company an "overweight" rating in a research note on Thursday.
Globus Medical, Inc. (NYSE:GMED) to Post FY2026 Earnings of $3.77 Per Share, Zacks Research Forecasts
Globus Medical, Inc. (NYSE:GMED - Free Report) - Stock analysts at Zacks Research increased their FY2026 earnings per share (EPS) estimates for shares of Globus Medical in a note issued to investors on Monday, May 6th. Zacks Research analyst R. Department now anticipates that the medical device c
Natixis Advisors L.P. Acquires 47,047 Shares of Globus Medical, Inc. (NYSE:GMED)
Natixis Advisors L.P. boosted its holdings in shares of Globus Medical, Inc. (NYSE:GMED - Free Report) by 45.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 150,114 shares of the medical device company's stock after buy
Globus Medical (NYSE:GMED) Releases Earnings Results, Beats Estimates By $0.17 EPS
Globus Medical (NYSE:GMED - Get Free Report) released its earnings results on Tuesday. The medical device company reported $0.72 earnings per share for the quarter, beating the consensus estimate of $0.55 by $0.17. The firm had revenue of $606.67 million for the quarter, compared to analyst estimates of $586.82 million. Globus Medical had a return on equity of 8.82% and a net margin of 7.83%. The company's quarterly revenue was up 119.3% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.53 earnings per share.
Piper Sandler Increases Globus Medical (NYSE:GMED) Price Target to $60.00
Piper Sandler boosted their price objective on Globus Medical from $55.00 to $60.00 and gave the company a "neutral" rating in a report on Wednesday.
Globus Medical (NYSE:GMED) Hits New 12-Month High Following Strong Earnings
Globus Medical (NYSE:GMED) Sets New 12-Month High After Earnings Beat
Globus Medical (NYSE:GMED) Earns Hold Rating from Needham & Company LLC
Needham & Company LLC reaffirmed a "hold" rating on shares of Globus Medical in a research report on Wednesday.
Globus Medical (NYSE:GMED) Issues FY 2024 Earnings Guidance
Globus Medical (NYSE:GMED) updated its FY 2024 earnings guidance. The company provided EPS guidance of 2.750-2.850 for the period, compared to the consensus estimate of 2.690. The company also issued revenue guidance of $2.5 billionillion-$2.5 billionillion, compared to the consensus estimate of $2.5 billionillion.
Globus Medical (NYSE:GMED) Updates FY24 Earnings Guidance
Globus Medical (NYSE:GMED) updated its FY24 earnings guidance. The company provided EPS guidance of $2.75-$2.85 for the period, compared to the consensus estimate of $2.69. The company also issued revenue guidance of $2.460-$2.485 billionillion, compared to the consensus estimate of $2.47 billionillion.
Globus Medical Reports First Quarter 2024 Results
Globus Medical A earnings preview: what to expect
Fisher Asset Management LLC Has $20.43 Million Stock Position in Globus Medical, Inc. (NYSE:GMED)
Fisher Asset Management LLC lowered its holdings in shares of Globus Medical, Inc. (NYSE:GMED - Free Report) by 24.7% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 383,433 shares of the medical device company's stock after selling 125,511 shares during the
River Global Investors LLP Invests $1.45 Million in Globus Medical, Inc. (NYSE:GMED)
River Global Investors LLP purchased a new position in Globus Medical, Inc. (NYSE:GMED - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 27,176 shares of the medical device company's
California Public Employees Retirement System Reduces Position in Globus Medical, Inc. (NYSE:GMED)
California Public Employees Retirement System cut its holdings in shares of Globus Medical, Inc. (NYSE:GMED - Free Report) by 15.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 176,302 shares of the
Get Globus Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for GMED and its competitors with MarketBeat's FREE daily newsletter.

He called Apple at $1.49 and now he says: “Buy these 6 AI stocks.” (Ad)

For over four decades, Louis Navellier has found the very best tech stocks... Before the rest of the market.

Click for his six specific AI stock in the crosshairs

GMED Media Mentions By Week

GMED Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

GMED
News Sentiment

0.85

0.42

Average
Medical
News Sentiment

GMED News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

GMED Articles
This Week

12

5

GMED Articles
Average Week

Get Globus Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for GMED and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NYSE:GMED) was last updated on 5/19/2024 by MarketBeat.com Staff

From Our Partners